Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-017383)

Filing Details

Accession Number:: 0001181431-13-017383
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-18 14:52:43
Reporting Period:: 2013-03-15

Filing Date:: 2013-03-18
Accepted Time:: 2013-03-18 14:52:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356857	Trius Therapeutics Inc	TSRX	Pharmaceutical Preparations (2834)	201320630

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479788	John Finn	C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 105 San Diego CA 92121	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-15	1,500	$7.10	190,360	No	4	S	Indirect	By The John and Debbie Finn Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The John and Debbie Finn Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,782	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012.
Includes 343 shares acquired May 18, 2012 and 465 shares acquired November 20, 2012 pursuant to the Issuer's Employee Stock Purchase Plan.